Multiple Myeloma Clinical Trials in Rochester, New York

4 studies are recruiting for multiple myeloma in Rochester, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events

    The purpose of this study is to identify preventive treatments that can minimize the occurrence, severity, and duration of talquetamab-related taste changes (dysgeusia), during the prophylaxis (preventive) treatment phase, to better characterize the signs or symptoms of talquetamab-related taste ch…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    University of Rochester Medical Center, Rochester, New York
    Locations
    38 in total
    Run by
    Janssen Research & Development, LLC

    See if you can join NCT06500884 on ClinicalTrials.gov

  2. Selinexor and Backbone Treatments of Multiple Myeloma Patients

    This study will independently assess the efficacy and safety of 11 combination therapies in 12 arms, in dose-escalation/-evaluation and expansion phases, for the treatment of patients with relapsed/refractory multiple myeloma (RRMM) and newly diagnosed multiple myeloma (NDMM). The combinations to b…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Wilmot Cancer Center/ University of Rochester, Rochester, New York
    Locations
    25 in total
    Run by
    Karyopharm Therapeutics Inc

    See if you can join NCT02343042 on ClinicalTrials.gov

  3. Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)

    Multiple myeloma is characterized by a pattern of recurrent relapse and remains an incurable malignancy. Participants with minimal residual disease (MRD) after front line therapy with induction and transplant have worse prognosis than those with MRD negative disease. Bispecific T-cell-based immunot…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Wilmot Cancer Center, Clinical Trial Office of the University of Rochester Medical Center, Rochester, New York
    Locations
    2 in total
    Run by
    Noffar Bar

    See if you can join NCT06993675 on ClinicalTrials.gov

  4. Umbilical Cord Blood Transplantation From Unrelated Donors

    This study is being done to determine how long it takes for the engraftment (recovery of blood cell counts) of umbilical cord stem cells and also how often engraftment of umbilical cord stem cells transplanted from an unrelated donor fails. Another purpose will be to document the rate of disease-fr…

    Stage
    Not phased
    Ages
    0 to 75
    Site
    Wilmot Cancer Institute, Rochester, New York
    Run by
    University of Rochester

    See if you can join NCT03016806 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.